ReNetX Bio, Inc, 157 Church St, Fl 19, New Haven, CT 06510, US

Intensity Therapeutics, Inc. is a cutting-edge biotechnology company based in Westport, CT, dedicated to revolutionizing cancer treatment. Their innovative intratumoral delivery technology allows for the development of drug products that effectively kill cancer cells while stimulating a systemic immune response, enabling immune cells to target tumors throughout the body. With a mission to extend the lives of patients with metastatic cancer and prevent disease recurrence, Intensity Therapeutics aims to make a significant impact on the field of oncology. Through their proprietary penetration enhancer platform technology, DfuseRx, Intensity Therapeutics enables therapeutic agents to be injected directly into solid tumors, improving absorption and facilitating the dispersion of the drug solution throughout the tumor. This localized cell death induces an influx of immune cells, triggering a system-wide immune response that targets not only the primary tumor but also distal cancer sites. With promising clinical results and a focus on personalized medicine, Intensity Therapeutics is at the forefront of developing novel treatments for various types of cancer.Generated from the website

Newton-Foster Home Care Agency

Philip R Digennaro

Bryan P Galat

N O C T S Y